UCBJY - FDA approves UCB's Bimzelx for plaque psoriasis October, 18 2023 10:49 AM UCB S.A. ADR 2023-10-18 10:49:13 ET More on UCB SA Seeking Alpha’s Quant Rating on UCB SA Historical earnings data for UCB SA Dividend scorecard for UCB SA Financial information for UCB SA For further details see: FDA approves UCB's Bimzelx for plaque psoriasis